The above demonstrated that miR-132 is effective in both impeding HCC cell growth (decreasing viability and undermining proliferation) and boosting HCC cell apoptosis (upturning the caspase-3/7 activity), which mutually supports the findings by both Wei, et al. [14], Liu, et al.[15] and us (Xin Zhang, et al. Down-regulation of MicroRNA-132 Indicates Progression in Hepatocellular Carcinoma: A Clinical Perspective. The gene discussed is CASP3; the disease is hepatocellular carcinoma.